<DOC>
	<DOCNO>NCT00900172</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This research study look blood tissue sample patient locally advance , metastatic , recurrent non-small cell lung cancer treat bevacizumab , carboplatin , paclitaxel .</brief_summary>
	<brief_title>Study Blood Tissue Samples From Patients With Locally Advanced , Metastatic , Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab , Carboplatin , Paclitaxel</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine whether germline polymorphism ( DNA ) gene involve DNA repair ( e.g. , XPD , ERCC-1 , others ) angiogenesis ( e.g. , vascular endothelial growth factor [ VEGF ] , interleukin-8 , CXCR2 , adrenomedullin , leptin , others ) associate toxicity clinical outcome patient non-small cell lung cancer enrol protocol ECOG-4599 . OUTLINE : Blood sample previously obtain patient protocol ECOG-4599 analyze association germline variation gene involve DNA repair ( XPD ERCC1 ) , angiogenesis ( VEGF IL-8 ) , clinical outcome ( overall survival , response , progression-free survival , toxicity ) . Tumor cell collect paraffin-embedded tissue use laser-capture microdissection normal tissue collect specimen . Polymorphisms ERCC-1 , XRCC-1 , XRCC-3 , GST-P1 , TGF-Î² , IL-8CXCR assess use Taqman assay .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Available serum plasma sample patient locally advance , metastatic , recurrent nonsquamous nonsmall cell lung cancer Stage IIIB ( pleural effusion ) stage IV disease Enrolled protocol ECOG4599 Treated carboplatin paclitaxel without bevacizumab PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
</DOC>